Drug targeting through platelet membrane-coated nanoparticles for the treatment of rheumatoid arthritis

Nano Research ◽  
2018 ◽  
Vol 11 (11) ◽  
pp. 6086-6101 ◽  
Author(s):  
Yuwei He ◽  
Ruixiang Li ◽  
Jianming Liang ◽  
Ying Zhu ◽  
Shuya Zhang ◽  
...  
2020 ◽  
Vol 1 (1) ◽  
pp. 2000018
Author(s):  
Shuyan Wang ◽  
Yaou Duan ◽  
Qiangzhe Zhang ◽  
Anvita Komarla ◽  
Hua Gong ◽  
...  

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
H Yang ◽  
Y Song ◽  
Z Huang ◽  
J Qian ◽  
Z Pang ◽  
...  

Abstract Background Aortic valve disease is the most common valvular heart disease leading to valve replacement. The efficacy of pharmacological therapy for aortic valve disease is limited by the high mechanical stress at the aortic valves impairing the binding rate. We aimed to identify nanoparticle coating with entire platelet membranes to fully mimic their inherent multiple adhesion mechanisms and target the sclerotic aortic valve of apolipoprotein E-deficient (ApoE−/−) mice based on their multiple sites binding capacity under high shear stress. Methods Considering the potent interaction of platelet membrane glycoproteins with components present in sclerotic aortic valves, platelet membrane-coated nanoparticles (PNPs) were synthetized and the binding capacity under high shear stress was evaluated in vitro and in vivo. Results Compared with PNPs bound intensity in the static station, 161%, 59%, and 39% of attached PNPs remained adherent on VWF-, collagen-, and fibrin-coated surfaces under shear stress of 25dyn/cm2 respectively. PNPs demonstrated effectively adhering to von Willebrand factor, collagen and fibrin under shear stresses in vitro. In an aortic valve disease model established in ApoE−/− mice, PNPs group exhibited significant increase of accumulation in the aortic valves compared with PBS and control NP group. PNPs displayed high degrees of proximity or co-localization with vWF, collagen and fibrin, which exhibited good targeting to sclerotic aortic valves by mimicking platelet multiple adhesive mechanisms. Conclusion PNPs could provide a promising platform for the molecular diagnosis and targeting treatment of aortic valve disease. Targeting combination Funding Acknowledgement Type of funding source: Foundation. Main funding source(s): National Natural Science Foundation of China


Nano Letters ◽  
2018 ◽  
Vol 19 (1) ◽  
pp. 124-134 ◽  
Author(s):  
Ruixiang Li ◽  
Yuwei He ◽  
Ying Zhu ◽  
Lixian Jiang ◽  
Shuya Zhang ◽  
...  

Engineering ◽  
2020 ◽  
Author(s):  
Jwa-Kyung Kim ◽  
Satoshi Uchiyama ◽  
Hua Gong ◽  
Alexandra Stream ◽  
Liangfang Zhang ◽  
...  

2020 ◽  
Vol 8 (21) ◽  
pp. 4648-4659 ◽  
Author(s):  
Long Wu ◽  
Wei Xie ◽  
Hui-Ming Zan ◽  
Zhongzhong Liu ◽  
Ganggang Wang ◽  
...  

Specific targeted drug delivery and controllable release of drugs at tumor regions are two of the main challenges for hepatocellular carcinoma (HCC) therapy, particularly post metastasis.


2021 ◽  
Author(s):  
Yi Zhao ◽  
Ruosen Xie ◽  
Nisakorn Yodsanit ◽  
Mingzhou Ye ◽  
Yuyuan Wang ◽  
...  

A schematic diagram of the PNPArg as a thrombus-targeting antithrombotic agent.


Nano Letters ◽  
2021 ◽  
Vol 21 (6) ◽  
pp. 2588-2595
Author(s):  
Bozhao Li ◽  
Tianjiao Chu ◽  
Jingyan Wei ◽  
Yinlong Zhang ◽  
Feilong Qi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document